MM

Mahlaka Mohammed Afzal Merchant

Active Director Designated Partner DIN 10958539
DIN 10958539 First appointment Feb 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahlaka Mohammed Afzal Merchant

Data last updated:

Mahlaka Mohammed Afzal Merchant is a Designated Partner at Renaibio Therapeutics Llp (since 2025).

DIN 10958539
Primary Designation Designated Partner
First Appointment 19 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Feb 20252025Active

Board colleagues of Mahlaka Mohammed Afzal Merchant

NameDINCompanyDesignation
Bilal Mohammedafzal Merchant10958540Renaibio Therapeutics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Renaibio Therapeutics Llp
Premium access

Shareholding and investment profile for Mahlaka Mohammed Afzal Merchant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahlaka Mohammed Afzal Merchant

Mahlaka Mohammed Afzal Merchant currently holds 1 directorship: Renaibio Therapeutics Llp (Designated Partner, since 19 Feb 2025).

Mahlaka Mohammed Afzal Merchant was first appointed on 19 Feb 2025 as Designated Partner at Renaibio Therapeutics Llp.

The current boards of Mahlaka Mohammed Afzal Merchant's companies include Bilal Mohammedafzal Merchant (Renaibio Therapeutics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available